Ro Khanna sold Novartis AG ADR (NYSE: NVS)
Ro Khanna (D-CA), a U.S. Representative, has disclosed 3 trades in Novartis AG ADR (NVS) since 2024, 1 purchase and 2 sales, worth an estimated $24K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Ro Khanna sold $1,001 - $15,000 of Novartis AG ADR (NYSE: NVS) on March 13, 2026. Since that trade, NVS is up +3.51% against the S&P 500 up +10.44%, an outperformance of -6.93%.
Across these filings, Ro Khanna has been a net seller of NVS (a buy-to-sell ratio of 0.50). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Ro Khanna's NVS trades vs the price
NVS is up +3.51% since Ro Khanna sold on March 13, 2026, versus +10.44% for the S&P 500.
Performance since this trade
All Ro Khanna NVS trades
Ro Khanna & NVS trading FAQ
Is it legal for Ro Khanna to trade Novartis AG ADR (NVS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novartis AG ADR (NVS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Ro Khanna sell NVS?
Ro Khanna disclosed a sale of $1,001 - $15,000 of Novartis AG ADR (NVS) on March 13, 2026, according to public STOCK Act filings.
How has NVS performed since Ro Khanna's trade?
Since Ro Khanna sold NVS on March 13, 2026, the stock is up +3.51%, versus +10.44% for the S&P 500 over the same period, an outperformance of -6.93%.
How many times has Ro Khanna traded NVS?
Ro Khanna has disclosed 3 NVS trades since 2024 (1 purchase and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVS trades?
Quantellect tracks every disclosed congressional trade in Novartis AG ADR (NVS) on the Novartis AG ADR congressional trading page, which aggregates filings across all members of Congress.
Ro Khanna's NVS tradesAll congressional filings for Novartis AG ADRRo Khanna's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.